Genix Pharmaceuticals (TSXV:GENX) EV-to-Revenue : 374.55 (As of Jun. 09, 2024)

Genix Pharmaceuticals EV-to-Revenue Chart

Genix Pharmaceuticals Annual Data
	Trend	Oct14	Oct15	Oct16	Oct17	Oct18	Oct19	Oct20	Oct21	Oct22	Oct23
EV-to-Revenue		Get a 7-Day Free Trial					19.09	-	-	-	239.08

Genix Pharmaceuticals Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EV-to-Revenue	Get a 7-Day Free Trial															1,922.22	272.30	305.42	239.08	266.81

Competitive Comparison of Genix Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genix Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's EV-to-Revenue falls into.

Genix Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Genix Pharmaceuticals's EV-to-Revenue for today is calculated as:

Genix Pharmaceuticals's current Enterprise Value is C$4.12 Mil.
Genix Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals  (TSXV:GENX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Genix Pharmaceuticals's PS Ratiofor today is calculated as:

Genix Pharmaceuticals's share price for today is C$0.06.
Genix Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genix Pharmaceuticals (TSXV:GENX) Business Description